Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers

Tumor burden and location as prognostic factors in patients treated by iodine seed implant brachytherapy for localized prostate cancers

Abstract Background Iodine seed implant brachytherapy is indicated for low risk and selected favorable intermediate risk prostate cancers. A percentage of positive biopsies > 50% is usually considered as a contra-indication, and the tumor location could also influence the treatment efficacy. We s...

Full description

Bibliographic Details
Main Authors: Claire Meynard, Andres Huertas, Charles Dariane, Sandra Toublanc, Quentin Dubourg, Saik Urien, Marc-Olivier Timsit, Arnaud Méjean, Nicolas Thiounn, Philippe Giraud
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Radiation Oncology
Subjects:
Prostate cancer
Iodine seed implant brachytherapy
Prostate biopsies
Tumor burden
Gleason score
Risk groups
Online Access:https://doi.org/10.1186/s13014-019-1449-z

Internet

https://doi.org/10.1186/s13014-019-1449-z

Similar Items